Home › Funds › Caligan Partners LP › ARTV
Caligan Partners LP position in ARTV
ARTIVA BIOTHERAPEUTICS INC · Health Care
Caligan Partners LP reported holding 1,481,043 shares of ARTV (ARTIVA BIOTHERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$10.5M, representing 0.65% of its reported portfolio and ranking #22 among its reported holdings. Caligan Partners LP has disclosed ARTV holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Caligan Partners LP's ARTV position evolved
Caligan Partners LP first disclosed a stake in ARTV in Q2 2026 at 1,736,111 shares (US$16.8M). Across 2 filings, Caligan Partners LP increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,481,043 shares valued at US$10.5M — a reduction of -255,068 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 1.74M | $16.84M | New |
| Q3 2026 | 1.48M | $10.55M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ARTV and 13F data
ARTV (ARTIVA BIOTHERAPEUTICS INC) is a Health Care company. 87 other funds we track also report a position in ARTV — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$220.2M), 5AM Venture Management, LLC (US$139.1M), Deep Track Capital, LP (US$73.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ARTV
- RA CAPITAL MANAGEMENT, L.P. 23.79M sh · $220.20M · Q3 2026
- 5AM Venture Management, LLC 9.68M sh · $139.10M · Q3 2026
- Deep Track Capital, LP 4.41M sh · $73.62M · Q3 2026
- Blue Owl Capital Holdings LP 4.13M sh · $63.84M · Q3 2026
- Foresite Capital Management V, LLC 3.56M sh · $59.50M · Q3 2026
- Foresite Capital Management VI LLC 2.20M sh · $36.80M · Q3 2026
- Cormorant Asset Management, LP 1.82M sh · $30.32M · Q3 2026
- ORBIMED ADVISORS LLC 1.68M sh · $27.98M · Q3 2026
- Venrock Adviser, LLC 2.04M sh · $14.55M · Q3 2026
- Sanofi 672.78K sh · $11.24M · Q3 2026
- Samsara BioCapital, LLC 954.86K sh · $6.80M · Q3 2026
- Saturn V Capital Management LP 300.36K sh · $5.02M · Q3 2026
More on Caligan Partners LP
FAQ
How long has Caligan Partners LP held ARTV?
Caligan Partners LP has disclosed ARTV holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is Caligan Partners LP's current position in ARTV?
As of Q3 2026, Caligan Partners LP holds 1.48M shares of ARTV (ARTIVA BIOTHERAPEUTICS INC), valued at $10.55M, representing 0.65% of its reported portfolio and ranking #22.
Has Caligan Partners LP been buying or selling ARTV?
In the latest 13F filing (Q3 2026), Caligan Partners LP reduced its position in ARTV.
Which other funds hold ARTV?
Other major institutional holders of ARTV include RA CAPITAL MANAGEMENT, L.P., 5AM Venture Management, LLC, Deep Track Capital, LP, among 87 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.